Welcome to our dedicated page for Ryan Specialty Hldgs SEC filings (Ticker: RYAN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Ryan Specialty Holdings, Inc. (NYSE: RYAN) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Ryan Specialty is an international specialty insurance firm that serves insurance brokers, agents, and carriers through distribution, underwriting, product development, administration, and risk management services, and its filings offer detailed insight into how this business is structured and performs.
Investors can review current reports on Form 8-K, where Ryan Specialty discloses material events. Recent 8-K filings have covered topics such as quarterly financial results and the associated earnings press releases, regular quarterly dividends on Class A common stock, appointments and retirements of directors, and changes in executive roles, including the appointment of Co-Presidents and related governance matters. These filings often incorporate press releases by reference, providing context for operational and governance decisions.
In addition to 8-Ks, users can access Ryan Specialty’s annual reports on Form 10-K and quarterly reports on Form 10-Q, which contain comprehensive financial statements, segment information for specialties such as Wholesale Brokerage, Binding Authority, and Underwriting Management, and discussions of non-GAAP measures like Organic Revenue Growth Rate, Adjusted EBITDAC, and Adjusted net income. These documents also include risk factor discussions and other disclosures relevant to the specialty insurance business.
Stock Titan enhances these filings with AI-powered summaries that highlight key points from lengthy documents, helping readers understand revenue composition, expense ratios, non-GAAP metrics, and governance changes without reading every page. The platform updates in near real time as new RYAN filings are posted to EDGAR, and also surfaces information related to dividends and board decisions. For users researching RYAN stock, this filings hub offers a structured way to analyze Ryan Specialty’s regulatory history and ongoing reporting obligations.
Ryan Specialty Holdings EVP & CHRO Michael Conklin exercised restricted stock units and settled related taxes in shares. On April 1, he converted 7,637 Restricted Stock Units into 7,637 shares of Class A Common Stock. Of these, 2,176 shares were withheld at $33.74 per share to cover tax obligations.
After these transactions, he directly held 10,196 shares of Class A Common Stock and 22,908 Restricted Stock Units, which each represent a contingent right to receive one share of Class A Common Stock as they vest in equal annual installments beginning April 1, 2025.
Ryan Specialty Holdings Inc Schedule 13G/A shows The Vanguard Group reporting 0 shares beneficially owned and 0% of the common stock following an internal realignment. The filing states certain Vanguard subsidiaries will report holdings separately in reliance on SEC Release No. 34-39538, effective with the realignment on 01/12/2026. The form is signed by Ashley Grim on 03/27/2026.
Ryan Specialty Holdings reports strong 2025 operating results and strategic progress. Revenue surpassed $3.0 billion, up 21% year-over-year, driven by 10.1% organic revenue growth and M&A. Adjusted EBITDAC grew 19.2% to $967 million with an Adjusted EBITDAC margin of 31.7%. The business expanded delegated authority revenue to $1.4 billion (representing 47% of total revenue), grew products to over 300, and completed 12 acquisitions totaling nearly $2.7 billion invested since inception, including five 2025 acquisitions with trailing revenue over $125 million. The Board authorized a $300 million share repurchase program and approved an 8% increase to the regular quarterly dividend. Management launched a three-year restructuring program, EMPOWER, to drive operational efficiencies and margin expansion over time.
Ryan Specialty Holdings is asking stockholders to vote at its virtual 2026 annual meeting on April 28, 2026 on three items: electing five directors, ratifying Deloitte & Touche as auditor, and approving an advisory vote on executive pay. The proxy highlights a strong 2025, with revenue surpassing $3 billion, up 21% year-over-year, marking the 15th straight year of double‑digit organic growth and the seventh consecutive year of total revenue growth above 20%. The company invested nearly $2.7 billion in 12 acquisitions over two years and launched EMPOWER, a three‑year restructuring program to streamline operations and advance data, technology, and AI initiatives. The Board also authorized a $300 million inaugural share repurchase program and approved an 8% increase in the regular quarterly dividend, emphasizing a capital return mix alongside ongoing M&A and organic investment. The filing describes a largely independent Board, a phased declassification to annual director elections, majority voting in uncontested elections, and expanded stockholder rights such as written consents and the ability to call special meetings.
Ryan Specialty Holdings, Inc. reported that Co-President and COO Stephen Patrick Keogh acquired a grant of 24,869 Restricted Stock Units on the reported date. The units were recorded at a transaction price of $0.0000 per unit, reflecting an equity award rather than an open-market purchase.
Each Restricted Stock Unit represents a contingent right to receive, upon vesting, one share of the company’s Class A common stock. According to the grant terms, these units vest in three equal annual installments beginning on April 1, 2029, tying the award to long-term service and performance.
RYAN Specialty Holdings, Inc. reported that Co-President and CRO Brendan Martin Mulshine acquired a grant of 24,869 Restricted Stock Units on March 3, 2026. Each RSU represents a contingent right to receive one share of Class A common stock, vesting in three equal annual installments beginning on April 1, 2029.
Hamilton Janice M reported acquisition or exercise transactions in this Form 4 filing.
RYAN Specialty Holdings, Inc. Chief Financial Officer Janice M. Hamilton reported receiving a grant of 29,843 Restricted Stock Units on March 3, 2026. Each Restricted Stock Unit represents a contingent right to receive one share of the company’s Class A common stock upon vesting.
The Restricted Stock Units vest in three equal annual installments beginning on April 1, 2029. Following this award, Hamilton held 29,843 Restricted Stock Units as of the transaction date, all reported as directly owned.
Wuller Benjamin MIles reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings CEO Benjamin Miles Wuller reported an equity award of 24,869 Restricted Stock Units. Each unit represents a contingent right to receive one share of Class A common stock upon vesting. These RSUs vest in three equal annual installments beginning on April 1, 2029, and are held directly.
Ryan Specialty Holdings, Inc. reported that EVP & CHRO Michael Conklin acquired 24,869 Restricted Stock Units as a grant. Each unit represents a contingent right to receive one share of Class A common stock on vesting. The Restricted Stock Units vest in three equal annual installments beginning on April 1, 2029.
KATZ MARK STEPHEN reported acquisition or exercise transactions in this Form 4 filing.
Ryan Specialty Holdings, Inc. granted Executive Vice President and General Counsel Mark Stephen Katz 24,869 Restricted Stock Units on March 3, 2026. The award was recorded at a price of $0.0000 per unit, reflecting its nature as an equity compensation grant rather than a cash purchase.
Each Restricted Stock Unit represents a contingent right to receive one share of Ryan Specialty Class A common stock upon vesting. According to the filing, these RSUs vest in three equal annual installments beginning on April 1, 2029, aligning Mr. Katz’s compensation with long-term shareholder interests over a multi-year period.